Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Non-Current Debt (2019 - 2021)

Historic Non-Current Debt for CureVac (CVAC) over the last 3 years, with Q3 2021 value amounting to $32.5 million.

  • CureVac's Non-Current Debt changed N/A to $32.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $32.5 million, marking a year-over-year change of. This contributed to the annual value of $30.0 million for FY2020, which is 5826.93% down from last year.
  • As of Q3 2021, CureVac's Non-Current Debt stood at $32.5 million.
  • In the past 5 years, CureVac's Non-Current Debt ranged from a high of $72.0 million in Q4 2019 and a low of $30.0 million during Q4 2020
  • For the 3-year period, CureVac's Non-Current Debt averaged around $41.7 million, with its median value being $32.3 million (2021).
  • The largest annual percentage gain for CureVac's Non-Current Debt in the last 5 years was 5826.93% (2020), contrasted with its biggest fall of 5826.93% (2020).
  • Over the past 3 years, CureVac's Non-Current Debt (Quarter) stood at $72.0 million in 2019, then crashed by 58.27% to $30.0 million in 2020, then rose by 8.15% to $32.5 million in 2021.
  • Its Non-Current Debt was $32.5 million in Q3 2021, compared to $32.2 million in Q2 2021 and $30.0 million in Q4 2020.